Genomic Health Inc (NASDAQ:GHDX): Julian Baker And Felix Baker’s Baker Bros. Advisors filed an amended 13D.
You can check out Baker Bros. Advisors’ latest holdings and filings here.
Please follow Baker Bros. Advisors (if you aren’t already doing so) to get real-time email alerts whenever we publish an article about Baker Bros. Advisors or update its stock holdings.
Follow Julian Baker And Felix Baker's Baker Bros. Advisors
You can access the original SEC filing by clicking here.
Ownership Summary Table
| Name | Sole Voting Power | Shared Voting Power | Sole Dispositive Power | Shared Dispositive Power | Aggregate Amount Owned Power | Percent of Class |
|---|---|---|---|---|---|---|
| Baker Bros. Advisors | 13,918,966 | 0 | 13,918,966 | 0 | 13,918,966 | 39.9% |
| Baker Bros. Advisors (GP) | 13,918,966 | 0 | 13,918,966 | 0 | 13,918,966 | 39.9% |
| Julian C. Baker | 14,092,863 | 0 | 14,092,863 | 0 | 14,092,863 | 40.4% |
| Felix J. Baker | 14,092,863 | 0 | 14,092,863 | 0 | 14,092,863 | 40.4% |
| FBB Associates | 173,897 | 0 | 173,897 | 0 | 173,897 | 0.5% |
Follow Julian Baker And Felix Baker's Baker Bros. Advisors
Page 1 of 12 – SEC Filing
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, DC 20549
SCHEDULE 13D
Under the Securities Exchange Act of
1934
(Amendment No.
33)
Genomic Health,
Inc.
(Name of Issuer)
Common Stock,
par value $0.0001 per share
(Title of Class of Securities)
37244C101
(CUSIP number)
Alexandra A. Toohey
Chief Financial Officer
Baker Bros. Advisors LP
860 Washington Street, 3rd Floor
New York, NY 10014
(212) 339-5690
(Name, address and telephone number of person
authorized to receive notices and communications)
March 8, 2018
(Date of event which requires filing of
this statement)
If
the filing person has previously filed a statement on Schedule 13G to report the acquisition that is the subject of this Schedule
13D, and is filing this schedule because of Rule 13d-1(e), 13d-1(f) or 13d-1(g), check the following box. ¨
(Continued on the following pages)
Note: Schedules filed in paper format shall include a
signed original and five copies of the schedule, including all exhibits. See Rule 13d-7 for other parties to whom copies are to
be sent.
* The remainder of this cover page shall be filled out for
a reporting person’s initial filing on this form with respect to the subject class of securities, and for any
subsequent amendment containing information which would alter disclosures provided in a prior cover page.
The information required on the remainder of this cover page
shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934 (“Act”)
or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however,
see the Notes).
